1. Clinical utility of the 21-gene Oncotype DX® Recurrence Score® (RS) assay in hormone receptor-positive, HER2-negative breast cancer (BC). (March 2017) Authors: Lau, A.; Miller, D.; Davison, D.; Rothney, M.; Borgen, P. Journal: Breast Issue: Volume 32(2017)Supplement 1 Page Start: S97 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗